Health Care Market News Psychedelics Global healthcare leader acquires microcap psychedelic stock Otsuka Pharmaceutical has acquired Mindset Pharma, a microcap psychedelic stock developing drugs for psychiatric and neurological disorders. Trevor Abes2 mins31 August 2023 08:48 (EDT)75
Market News Psychedelics Cybin gears up to acquire Small Pharma Inc. Cybin (NEO:CYBN) is gearing up to acquire Small Pharma Inc. (TSXV:DMT) to create the psychedelics industry's largest DMT program. Jocelyn Aspa2 mins28 August 2023 12:40 (EDT)104
Market News Psychedelics World’s first psychedelic microdosing home trials ready for Phase 2 MindBio Therapeutics (CSE:MBIO) received the first batch of its drug for take-home use in Phase 2 psychedelic microdosing clinical trials. Jon Brown2 mins18 August 2023 09:25 (EDT)78
Market News Psychedelics The biotech/pharma team set up to enhance psychedelic therapeutics Clearmind Medicine (CSE:CMND) has agreed to collaborate on product development with pharmaceutical and consumer products company CTS Ltd. Jon Brown2 mins14 August 2023 09:19 (EDT)58
Market News Psychedelics Red Light Holland starts stability testing for psilocybin capsules Red Light Holland (CSE:TRIP) begins stability testing for its psilocybin microdosing capsules The capsules were developed... Jocelyn Aspa2 mins19 June 2023 12:20 (EDT)73
Consumer Health Care Market News Psychedelics Mushroom Home Grow Kits now available at Canadian Tire Red Light Holland (CSE:TRIP) has expanded its Mushroom Home Grow Kits distribution to 36 Canadian Tire... Jon Brown2 mins16 June 2023 08:58 (EDT)141
Market News Psychedelics Optimi Health to supply MDMA for therapist experiential training program Optimi Health (OPTI) will manufacture and supply MDMA for the program set to take place later... Brieanna McCutcheon2 mins15 June 2023 13:15 (EDT)93
Health Care Market News Psychedelics Psychedelics stock’s LSD clinical trial reports sleep quality breakthrough Psychedelics stock MindBio Therapeutics (CSE:MBIO) made a major discovery from sleep data from its LSD-microdosing trials... Jon Brown2 mins14 June 2023 08:59 (EDT)59
Health Care Market News Psychedelics Psychedelics company begins phase 3 psilocybin study for depression Psychedelics company Numinus Wellness has initiated a study on COMP360 psilocybin for treatment-resistant depression (TRD) as... Maor Kagan2 mins30 May 2023 12:43 (EDT)82
Health Care Market News Psychedelics Psychedelics stock moving forward with pioneering LSD clinical trial Psychedelics stock MindBio Therapeutics receives ethics approval for its Phase 2a take-home LSD microdosing clinical trial... Trevor Abes2 mins23 May 2023 08:26 (EDT)86
Health Care Market News Psychedelics Clearmind (CSE:CMND) approved to conduct clinical trial on alcohol use disorder Clearmind (CMND) received approval for its CMND-100 compound to treat alcohol use disorder at Israel’s IMCA... Jon Brown2 mins12 May 2023 09:50 (EDT)101
Market News Psychedelics Optimi Health (CSE:OPTI) granted a Natural Health Product Site Licence by Health Canada Optimi Health (OPTI) has received a Natural Health Product Site Licence by Health Canada The licence also... Jon Brown2 mins10 May 2023 09:08 (EDT)155
Health Care Psychedelics The Watchlist Psyched Wellness (CSE:PSYC) and HealingMaps to offer Amanita Muscaria tincture, Calm, to HealingMaps universe This is sponsored content issued on behalf of Psyched Wellness, please see full disclaimer here. Trevor Abes1 min09 May 2023 13:48 (EDT)84
Health Care Market News Psychedelics MindBio Therapeutics (CSE:MBIO) begins trading on the CSE MindBio Therapeutics (MBIO) is now trading on the Canadian Securities Exchange MindBio is among a select... Trevor Abes2 mins05 May 2023 10:30 (EDT)303
Market News Psychedelics Optimi Health (CSE:OPTI) notches C$1.2 million psilocybin supply agreement Optimi Health Corp. (OPTI) enters into a C$1.2 million agreement to focus on developing mushroom-based therapeutic... Jocelyn Aspa1 min04 May 2023 11:23 (EDT)65
Health Care Market News Psychedelics Clearmind (CSE:CMND) signs supply agreement for its upcoming clinical trial Clearmind (CMND) has signed an agreement with IMP Clinical Supply Services IMP will be responsible for... Jon Brown2 mins02 May 2023 09:00 (EDT)52
Health Care Market News Psychedelics Nova Mentis (CSE:NOVA) enters mRNA AI diagnostics business Nova Mentis’ (NOVA) wholly owned subsidiary, Pilz Bioscience Inc. will change its name to to SwabAi... Jon Brown2 mins26 April 2023 09:18 (EDT)83
Consumer Market News Psychedelics Psyched Wellness (CSE:PSYC) lists Calm in all locations of Good Earth Markets Psyched (PSYC) announced that Calm continues to expand within brick and mortar retailers by listing at... Shoran Devi2 mins25 April 2023 10:20 (EDT)85
Market News Psychedelics Red Light Holland (CSE:TRIP) notches certificate of analysis for psilocybin truffles Red Light Holland (TRIP) notches certificate of analysis for psilocybin truffles The analysis was done by... Jocelyn Aspa1 min21 April 2023 10:58 (EDT)141
Health Care Market News Psychedelics Clearmind (CSE:CMND) expands portfolio with patent application to treat depression Clearmind (CMND) has filed a patent application to protect its combination to treat depression The company... Jon Brown1 min21 April 2023 09:02 (EDT)163
